64.12BMarket Cap14.60P/E (TTM)
167.00High159.88Low8.30KlotVolume164.95Open164.95Pre Close134.42MTurnover0.92%Turnover RatioLossP/E (Static)401.00MShares215.7152wk High12.44P/B14.46BFloat Cap76.3252wk Low197.94Limit Up90.45MShs Float215.71Historical High131.96Limit Down4.32%Amplitude28.75Historical Low--Dividend TTM161.95Avg Price4.50KlotAsk--Div YieldTTM100Lot Size3.32KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet